Who owns iShares NASDAQ Biotechnology Index?

Key details on iShares NASDAQ Biotechnology Index (Ticker: IBB)

Who owns iShares NASDAQ Biotechnology Index?

Is IBB a good stock to own? Find out who bought iShares NASDAQ Biotechnology Index, who sold iShares NASDAQ Biotechnology Index (IBB) stock, and who holds a large position in iShares NASDAQ Biotechnology Index.

Fund Name Number of Shares Share Valuation As Of
GOLDMAN SACHS 3.07M $1.05B March 31, 2015
Citi 2.60M $710.59M Sept. 30, 2014
MORGAN STANLEY 1.78M $540.14M Dec. 31, 2014
JPMORGAN CHASE & CO 1.55M $534.06M March 31, 2015
Deutsche Bank Aktiengesellschaft 1.54M $467.06M Dec. 31, 2014
Bank of America Corporation 1.50M $456.47M Dec. 31, 2014
SUSQUEHANNA INTERNATIONAL 1.40M $383.98M Sept. 30, 2014
UBS AG 1.40M $383.28M Sept. 30, 2014
Schroder Investment Management 1.37M $287.49M Sept. 30, 2013
Archer Capital Management 980000 $81.15M March 31, 2012
UBS Group AG 875555 $300.70M March 31, 2015
JANE STREET 737277 $253.20M March 31, 2015
Allianz Asset Management AG 546441 $114.53M Sept. 30, 2013
Barclays 537180 $162.77M Dec. 31, 2014
Credit Suisse AG 472374 $143.29M Dec. 31, 2014
Bank of Nova Scotia 456000 $103.54M Dec. 31, 2013
SERENGETI ASSET MANAGEMENT 450000 $136.51M Dec. 31, 2014
HAP Trading 438300 $7.49M Sept. 30, 2014
Mirae Asset Global Investments 408643 $105.23M June 30, 2014
Beaumont Financial Partners 361274 $124.14M June 30, 2015
OrbiMed Advisors 350000 $43.16M March 31, 2012
Churchill Management 335178 $123.67M June 30, 2015
LPL Financial 319571 $45.57M Sept. 30, 2012
MANAGED ACCOUNT ADVISORS 308111 $93.47M Dec. 31, 2014
Wells Fargo & Company 299395 $38.91M June 30, 2012
Arrowgrass Capital Partners 286600 $65.08M Dec. 31, 2013
Rathbones Brothers 276802 $8.89M March 31, 2014
Perceptive Advisors 269400 $46.84M June 30, 2013

Who sold iShares NASDAQ Biotechnology Index?

Fund Name Date Sold Number of Shares Sold Share Valuation
Johnson Investment Counsel June 30, 2011 8.02M $543.35M
Royal Bank of Scotland June 30, 2011 710459 $75.78M